302 related articles for article (PubMed ID: 10793931)
1. [Tolerance of acellular pertussis vaccine booster injection in 15-20-month-old children].
Mallet E; Puyt A; Arson S; Surbled V
Arch Pediatr; 2000 Apr; 7(4):410-4. PubMed ID: 10793931
[TBL] [Abstract][Full Text] [Related]
2. Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants.
Blennow M; Granström M
Pediatrics; 1989 Jul; 84(1):62-7. PubMed ID: 2544850
[TBL] [Abstract][Full Text] [Related]
3. Pertussis in adults: possible use of booster doses for control.
Hewlett EL
Tokai J Exp Clin Med; 1988; 13 Suppl():125-8. PubMed ID: 3078801
[TBL] [Abstract][Full Text] [Related]
4. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
Liese JG; Stojanov S; Belohradsky BH
Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
[TBL] [Abstract][Full Text] [Related]
5. [Acellular pertussis vaccine (Pa)].
Magdzik W
Przegl Epidemiol; 1995; 49(3):325-9. PubMed ID: 7491431
[TBL] [Abstract][Full Text] [Related]
6. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
7. [Acellular anti-pertussis vaccine].
Bégué P; Grimpel E; Baron S
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):859-65. PubMed ID: 1819434
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
9. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
10. Cellular and acellular pertussis vaccines in adults.
Keitel WA
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S118-23. PubMed ID: 10447029
[TBL] [Abstract][Full Text] [Related]
11. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants.
Leuridan E; Hens N; Peeters N; de Witte L; Van der Meeren O; Van Damme P
Pediatr Infect Dis J; 2011 Jul; 30(7):608-10. PubMed ID: 21206396
[TBL] [Abstract][Full Text] [Related]
12. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
[TBL] [Abstract][Full Text] [Related]
13. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
[TBL] [Abstract][Full Text] [Related]
14. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
Elomaa A; He Q; Minh NN; Mertsola J
Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis.
Purdy KW; Hay JW; Botteman MF; Ward JI
Clin Infect Dis; 2004 Jul; 39(1):20-8. PubMed ID: 15206048
[TBL] [Abstract][Full Text] [Related]
16. [Time for booster doses against whooping cough for 10-year-old children].
Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
Chan SH; Tan PT; Han HH; Bock HL
Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
[TBL] [Abstract][Full Text] [Related]
18. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations.
Gardner P
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S131-5. PubMed ID: 10447031
[TBL] [Abstract][Full Text] [Related]
19. Acellular pertussis vaccines: new preparation. Better tolerated but less active?
Prescrire Int; 2000 Feb; 9(45):204-7. PubMed ID: 11503797
[TBL] [Abstract][Full Text] [Related]
20. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
Wilson TR
J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
